Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Delayed estrogen actions diminish food consumption without changing food approach, motor activity, or hypothalamic activation elicited by corticostriatal µ-opioid signaling
    Published on 2023-08-28
    3 years ago
  • Correction: High-intensity sweet taste as a predictor of subjective alcohol responses to the ascending limb of an intravenous alcohol prime: an fMRI study
    Published on 2023-08-28
    3 years ago
  • Correction: Accelerated TMS – moving quickly into the future of depression treatment
    Published on 2023-08-28
    3 years ago
  • Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits
    Published on 2023-08-22
    3 years ago
  • Novel mechanism-based treatments for pediatric anxiety and depressive disorders
    Published on 2023-08-22
    3 years ago
  • Ensuring psychedelic treatments and research do not leave anyone behind
    Published on 2023-08-21
    3 years ago
  • Epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose
    Published on 2023-08-16
    3 years ago
« Previous 1 … 104 105 106 107 108 … 143 Next »
Journal of Psychopharmacology
  • The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling
    Published on 2020-10-24
    6 years ago
  • Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment
    Published on 2020-10-21
    6 years ago
  • Histamine H3 receptor gene variants associated with drug abuse in patients with cocaine use disorder
    Published on 2020-10-16
    6 years ago
  • Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking
    Published on 2020-10-16
    6 years ago
  • The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence
    Published on 2020-10-11
    6 years ago
  • Paternal exposure to morphine during adolescence potentiates morphine withdrawal in male offspring: Involvement of the lateral paragigantocellularis nucleus
    Published on 2020-10-09
    6 years ago
  • Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention
    Published on 2020-10-09
    6 years ago
« Previous 1 … 104 105 106 107 108 … 145 Next »
European Neuropsychopharmacology
  • Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys
    Published on 2021-04-26
    5 years ago
  • Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
    Published on 2021-04-26
    5 years ago
  • Bipolar disorder cohort studies: Crucial, but underfunded
    Published on 2021-04-23
    5 years ago
  • Anterior cingulate cortex neuro-metabolic changes underlying lithium-induced euthymia in bipolar depression: A longitudinal 1H-MRS study
    Published on 2021-04-19
    5 years ago
  • Editorial
    Published on 2021-04-17
    5 years ago
  • Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise
    Published on 2021-04-13
    5 years ago
  • The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years
    Published on 2021-04-12
    5 years ago
« Previous 1 … 104 105 106 107 108 … 166 Next »

   Pharma Pub